Difference between revisions of "FEMA5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(6 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
+ | |||
+ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big> | |+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big> | ||
Line 17: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |CHAPTER 2 (TUMOURS OF THE OVARY) | + | | |
+ | ==== CHAPTER 2 (TUMOURS OF THE OVARY) ==== | ||
| | | | ||
---- | ---- | ||
Line 807: | Line 810: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) | + | | |
+ | ==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ==== | ||
| | | | ||
---- | ---- | ||
Line 838: | Line 842: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 4 (TUMOURS OF THE PERITONEUM) | + | | |
+ | ==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,122: | Line 1,127: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) | + | | |
+ | ==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,296: | Line 1,302: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) | + | | |
+ | ==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,404: | Line 1,411: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) | + | | |
+ | ==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,743: | Line 1,751: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) | + | | |
+ | ==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,873: | Line 1,882: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) | + | | |
+ | ==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,234: | Line 2,244: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 10 (TUMOURS OF THE VAGINA) | + | | |
+ | ==== CHAPTER 10 (TUMOURS OF THE VAGINA) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,507: | Line 2,518: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 11 (TUMOURS OF THE VULVA) | + | | |
+ | ==== CHAPTER 11 (TUMOURS OF THE VULVA) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,736: | Line 2,748: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) | + | | |
+ | ==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,800: | Line 2,813: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) | + | | |
+ | ==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ==== | ||
| | | | ||
---- | ---- | ||
Line 2,886: | Line 2,900: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) | + | | |
+ | ==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ==== | ||
| | | | ||
---- | ---- | ||
Line 3,203: | Line 3,218: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 15 (MELANOCYTIC LESIONS) | + | | |
+ | ==== CHAPTER 15 (MELANOCYTIC LESIONS) ==== | ||
| | | | ||
---- | ---- | ||
Line 3,289: | Line 3,305: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 16 (METASTASIS) | + | | |
+ | ==== CHAPTER 16 (METASTASIS) ==== | ||
| | | | ||
---- | ---- | ||
Line 3,320: | Line 3,337: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) | + | | |
+ | ==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ==== | ||
| | | | ||
---- | ---- | ||
Line 3,342: | Line 3,360: | ||
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]] | |[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[FEMA5:Lynch_syndrome|Lynch syndrome]] | |[[FEMA5:Lynch_syndrome|Lynch syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[FEMA5:Cowden_syndrome|Cowden syndrome]] | |[[FEMA5:Cowden_syndrome|Cowden syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | |[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
Line 3,397: | Line 3,415: | ||
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | |[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[FEMA5:Carney_complex|Carney complex]] | |[[FEMA5:Carney_complex|Carney complex]] | ||
Line 3,419: | Line 3,437: | ||
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]] | |[[FEMA5:DICER1_syndrome_|DICER1 syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]] | |[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]] |
Latest revision as of 14:14, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.